Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: absence of JAK2V617F does not mean absence of myeloproliferative neoplasm

Podobne zapisy

• Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
  od: Guy, Alexandre, i wsp.
  Wydane: (2020)
• JAK2(V617F)-mutant Vascular Niche Contributes to JAK2(V617F) Clonal Expansion in Myeloproliferative Neoplasms
  od: Lin, Chi Hua Sarah, i wsp.
  Wydane: (2016)
• Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms
  od: Saied A. Jaradat, i wsp.
  Wydane: (2015-12-01)
• Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative Neoplasms
  od: Stein, Brady L., i wsp.
  Wydane: (2011)
• Jak2V617F myeloproliferative neoplasm stem cells and interferon-alpha
  od: Lane, Steven W., i wsp.
  Wydane: (2013)